Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate Patent Expiration
Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate is Used for cleansing the colon as preparation for colonoscopy in adults. It was first introduced by Braintree Laboratories Inc
Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate Patents
Given below is the list of patents protecting Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Suprep Bowel Prep Kit | US6946149 | Salt solution for colon cleansing |
Mar 07, 2023
(Expired) | Braintree Labs |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate's patents.
Latest Legal Activities on Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate's Patents
Given below is the list recent legal activities going on the following patents of Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Change in Power of Attorney (May Include Associate POA) Critical | 01 Jul, 2021 | US6946149(Litigated) |
| Correspondence Address Change Critical | 30 Jun, 2021 | US6946149(Litigated) |
| Second letter to regulating agency to determine regulatory review period | 26 Jul, 2016 | US6946149(Litigated) |
| Mail-Petition Decision - Granted | 19 Mar, 2015 | US6946149(Litigated) |
| Notice of Final Determination- Ineligible | 18 Mar, 2015 | US6946149(Litigated) |
| Petition Decision - Granted Critical | 18 Mar, 2015 | US6946149(Litigated) |
| Petition Entered | 02 May, 2011 | US6946149(Litigated) |
| Patent Term Extension Application under 35 USC 156 Filed | 02 May, 2011 | US6946149(Litigated) |
| Letter from FDA or Dept of Agriculture re PTE application | 27 Apr, 2011 | US6946149(Litigated) |
| Initial letter Re: PTE Application to regulating agency | 21 Jan, 2011 | US6946149(Litigated) |
Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate's Family Patents
Explore Our Curated Drug Screens
Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate Generic API Manufacturers
Several generic applications have been filed for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate. The first generic version for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate was by Novel Laboratories Inc and was approved on Feb 23, 2017. And the latest generic version is by Annora Pharma Private Ltd and was approved on Oct 18, 2024.
Given below is the list of companies who have filed for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate generic, along with the locations of their manufacturing plants worldwide.
1. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 1 generic for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate. This 1.6gm/bot;3.13gm/bot;17.5gm/bot version comes by the name SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.6GM/BOT; 3.13GM/BOT; 17.5GM/BOT | solution | Prescription | ORAL | AA | Dec 29, 2023 |
2. ANNORA PHARMA
Annora Pharma Private Ltd has filed for 1 generic for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate. This 1.6gm/bot;3.13gm/bot;17.5gm/bot version comes by the name SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE. Given below are the details of the strengths of this generic introduced by Annora Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.6GM/BOT; 3.13GM/BOT; 17.5GM/BOT | solution | Prescription | ORAL | AA | Oct 18, 2024 |
Manufacturing Plant Locations New
Annora Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Annora Pharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
3. BIONPHARMA
Bionpharma Inc has filed for 1 generic for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate. This 1.6gm/bot;3.13gm/bot;17.5gm/bot version comes by the name SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE. Given below are the details of the strengths of this generic introduced by Bionpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.6GM/BOT; 3.13GM/BOT; 17.5GM/BOT | solution | Prescription | ORAL | AA | Jun 24, 2024 |
Manufacturing Plant Locations New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
4. NOVEL LABS INC
Novel Laboratories Inc has filed for 1 generic for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate. This 1.6gm/bot;3.13gm/bot;17.5gm/bot version comes by the name SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE. Given below are the details of the strengths of this generic introduced by Novel Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.6GM/BOT; 3.13GM/BOT; 17.5GM/BOT | solution | Prescription | ORAL | AA | Feb 23, 2017 |
5. PAI HOLDINGS
Pai Holdings Llc Dba Pharmaceutical Associates Inc And Dba Pai Pharma has filed for 1 generic for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate. This 1.6gm/bot;3.13gm/bot;17.5gm/bot version comes by the name SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE. Given below are the details of the strengths of this generic introduced by Pai Holdings.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.6GM/BOT; 3.13GM/BOT; 17.5GM/BOT | solution | Prescription | ORAL | AA | Jul 15, 2024 |
Manufacturing Plant Locations New
Pai Holdings's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Pai Holdings as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
6. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 1 generic for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate. This 1.6gm/bot;3.13gm/bot;17.5gm/bot version comes by the name SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.6GM/BOT; 3.13GM/BOT; 17.5GM/BOT | solution | Prescription | ORAL | AA | Nov 22, 2023 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||
7. TARO
Taro Pharmaceutical Industries Ltd has filed for 1 generic for Magnesium Sulfate; Potassium Sulfate; Sodium Sulfate. This 1.6gm/bot;3.13gm/bot;17.5gm/bot version comes by the name SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.6GM/BOT; 3.13GM/BOT; 17.5GM/BOT | solution | Prescription | ORAL | AA | Mar 19, 2024 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||